【Neuronetics Inc(STIM)投资者维权信息】
2021年10月12日Neuronetics Inc(STIM)公布了初步收入结果,预计第三季度的总收入约为 1380 万美元,而此前发布的指导为 1500 万美元至 1600 万美元。公司还下调了全年收入指引,预计 2021 财年在 5,330 万美元至 5,430 万美...查看全文
蹊之美股生物医药2021-08-04 23:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Arcturus Therapeutics (NASDAQ:ARCT) +68%
Flora Growth (NASDAQ:FLGC) +62%
Translate Bio (NASDAQ:TBIO) +29%
Outlook Therapeutics (NASDAQ:OTLK) +6%
Losers:
Neuronet...查看全文
$Neuronetics(STIM)$ D - Notice of Exempt Offering of Securities Filed: 2017-06-13 AccNo: 0001192482-17-000168 Size: 13 KB 网页链接
$Neuronetics(STIM)$ D - Notice of Exempt Offering of Securities Filed: 2015-05-07 AccNo: 0001192482-15-000173 Size: 13 KB 网页链接
$Neuronetics(STIM)$ D - Notice of Exempt Offering of Securities Filed: 2014-12-03 AccNo: 0001192482-14-000249 Size: 12 KB 网页链接
$Neuronetics(STIM)$ D - Notice of Exempt Offering of Securities Filed: 2013-01-03 AccNo: 0001192482-13-000001 Size: 18 KBItem 06: Rule 506 网页链接
$Neuronetics(STIM)$ DRS/A [Amend] [Cover] - Draft Registration Statement Filed: 2018-05-29 AccNo: 0000950123-18-006005 Size: 7 MB 网页链接
$Neuronetics(STIM)$ DRS/A [Amend] [Cover] - Draft Registration Statement Filed: 2018-04-27 AccNo: 0000950123-18-003822 Size: 6 MB 网页链接
$Neuronetics(STIM)$ DRS [Cover] - Draft Registration Statement Filed: 2018-03-16 AccNo: 0000950123-18-003024 Size: 7 MB 网页链接